Measuring charge and mass distributions in dry powder inhalers using the electrical Next Generation Impactor (eNGI)

European Journal of Pharmaceutical Sciences

Volumn 38, Issue 2, 2009, Pages 88-94

  Hoe, Susan ^a   Traini, Daniela ^a   Chan, Hak Kim ^a   Young, Paul M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Budesonide; Dry powder inhaler; Electrical Next Generation Impactor (eNGI); Terbutaline; Triboelectrification

Indexed keywords

BUDESONIDE; TERBUTALINE;

AEROSOL; AIRFLOW; ANALYTICAL EQUIPMENT; ARTICLE; CONTROLLED STUDY; DRY POWDER; ELECTRIC POTENTIAL; ELECTRICAL LOW PRESSURE IMPACTOR; ELECTRICAL NEXT GENERATION IMPACTOR; FLOW RATE; NEXT GENERATION IMPACTOR; PARTICLE SIZE; POWDER INHALER; PRIORITY JOURNAL; VACUUM;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTRICITY; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDERS; STATIC ELECTRICITY;

EID: 68749092013     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.06.003     Document Type: Article

References (40)

1. Adi H., Traini D., Chan H.-K., and Young P.M. The influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulations. J. Pharm. Sci. 97 (2007) 2780-2788
2. Bailey A.G. Charging of solids and powders. J. Electrostat. 30 (1993) 167-180
3. Bailey A.G. The inhalation and depostion of charged particles within the human lung. J. Electrostat. 42 (1997) 25-32
4. Bailey A.G. The charging of insulator surfaces. J. Electrostat. 51/52 (2001) 82-90
5. Bennett F.S., Carter P.A., Rowley G., and Dandiker Y. Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles. Drug Dev. Ind. Pharm. 25 (1999) 99-103
6. Borgström L. On the use of dry powder inhalers in situations perceived as constrained. J. Aerosol Med. 14 (2001) 281-287
7. Borgström L., Asking L., and Thorsson L. Idealhalers or realhalers? A comparison of Diskus and Turbuhaler. Int. J. Clin. Pract. 59 (2005) 1488-1495
8. Broeders M.E.A.C., Molema J., Burnell P.K.P., and Folgering H.T.M. Ventolin Diskus and Inspyril Turbuhaler: an in vitro comparison. J. Aerosol Med. 18 (2005) 74-82
9. Byron P.R., Peart J., and Staniforth J. Aerosol electrostatics I: properties of fine powders before and after aerosolisation by dry powder inhalers. Pharm. Res. 14 (1997) 698-705
10. Chougule M.B., Padhi B.K., Jinturkar K.A., and Misra A. Development of dry powder inhalers. Recent Patents Drug Deliv. Formulat. 1 (2007) 11-21
11. de Boer A.H., Bolhuis G.K., Gjaltema D., and Hagedoorn P. Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers. Part 3: the effect of flow increase rate (FIR) on the in vitro drug release from the Pulmicort 200 Turbuhaler. Int. J. Pharm. 153 (1997) 67-77
12. Diaz A.F., and Felix-Navarro R.M. A semi-quantitative tribo-electric series for polymeric materials: the influence of chemical structure and properties. J. Electrostat. 62 (2004) 277-290
13. Elajnaf A., Carter P., and Rowley G. Electrostatic characterization of inhaled powders: effect of contact surface and relative humidity. Eur. J. Pharm. Sci. 29 (2006) 375-384
14. Feddah M.R., and Davies N.M. Influence of single versus multiple actuations on the particle size distribution of beclometasone dipropionate metered-dose inhalers. J. Pharm. Pharmacol. 55 (2003) 1055-1061
15. García-Hernández M., Bagus P.S., and Illas F. A new analysis of image charge theory. Surf. Sci. 409 (1998) 69-80
16. Glover W., and Chan H.-K. Electrostatic charge characterization of pharmaceutical aerosols using electrical low-pressure impactor (ELPI). J. Aerosol Sci. 35 (2004) 755-764
17. Grosvenor M.P., and Staniforth J.N. The influence of water on electrostatic charge retention and dissipation in pharmaceutical compacts for powder coating. Pharm. Res. 13 (1996) 1725-1729
18. Guchardi R., Frei M., John E., and Kaerger J.S. Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations. Int. J. Pharm. 348 (2008) 10-17
19. Hinds W.C. Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles (1999), John Wiley & Sons, Inc., New York
20. Hoe S., Young P.M., Chan H.-K., and Traini D. Introduction of the electrical Next Generation Impactor (eNGI) and investigation of its capabilities for the study of pressurized metered dose inhalers. Pharm. Res. 26 (2009) 431-437
21. Hogue M.D., Buhler C.R., Calle C.I., Matsuyama T., Luo W., and Groop E.E. Insulator-insulator contact charging and its relationship to contact pressure. J. Electrostat. 61 (2004) 259-268
22. Keskinen J., Pietarinen K., and Lehtimäki M. Electrical low pressure impactor. J. Aerosol Sci. 23 (1992) 353-360
23. Kwok P.C.L., and Chan H.-K. Electrostatic charge in pharmaceutical systems. In: Swarbrick J. (Ed). Encyclopedia of Pharmaceutical Technology (2005), Taylor & Francis, London 1535-1547
24. Kwok P.C.L., and Chan H.-K. Effect of relative humidity on the electrostatic charge properties of dry powder inhaler aerosols. Pharm. Res. 25 (2008) 277-288
25. Lacks D.J., and Levandovsky A. Effect of particle size distribution on the polarity of triboelectric charging in granular insulator systems. J. Electrostat. 65 (2007) 107-112
26. Marjamäki M., Keskinen J., Chen D.R., and Pui D.Y.H. Performance evaluation of the electrical low-pressure impactor. J. Aerosol Sci. 31 (2000) 249-261
27. Matsusaka S., and Masuda H. Electrostatics of particles. Adv. Powder Technol. 14 (2003) 143-166
28. Melandri C., Tarroni G., Prodi V., de Zaiacomo T., Formignani M., and Lombardi C.C. Deposition of charged particles in the human airways. J. Aerosol Sci. 14 (1983) 657-669
29. Mitchell J.P., and Nagel M.W. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations. J. Aerosol Med. 16 (2003) 341-377
30. Murtomaa M., Harjunen P., Mellin V., Lehto V., and Laine E. Effect of amorphicity on the triboelectrification of lactose powder. J. Electrostat. 56 (2002) 103-110
31. Newman S.P., Morén F., Trofast E., Talace N., and Clarke S.W. Terbutaline sulphate Turbuhaler: effect of inhaled flow rate on drug deposition and efficacy. Int. J. Pharm. 74 (1991) 209-213
32. Numura T., Satoh T., and Masuda H. The environment humidity effect on the tribo-charge of powder. Powder Technol. 135/136 (2003) 43-49
33. Prodi V., and Mularoni A. Electrostatic lung deposition experiments with humans and animals. Ann. Occup. Hyg. 29 (1985) 229-240
34. Rowley G. Quantifying electrostatic interactions in pharmaceutical solid systems. Int. J. Pharm. 227 (2001) 47-55
35. Saini D., Gunamgari J., Zulaloglou C., Sims R.A., and Mazumder M.K. Effect of electrostatic charge and size distributions on respirable aerosol deposition in lung model. In: Society I.I.A. (Ed). 39th Annual IAS Meeting (IEEE Industry Applications Society). IEEE, Seattle (2004)
36. Saleem I., Smyth H.D.C., and Telko M.J. Prediction of dry powder inhaler formulation performance from surface energetics and blending dynamics. Drug Dev. Ind. Pharm. 34 (2008) 1002-1010
37. Telko M.J., Kujanpää J., and Hickey A.J. Investigation of triboelectric charging in dry powder inhalers using electrical low pressure impactor (ELPI). Int. J. Pharm. 336 (2007) 352-360
38. Thielmann F., Burnett D.J., and Heng J.Y.Y. Determination of the surface energy distributions of different processed lactose. Drug Dev. Ind. Pharm. 33 (2007) 1240-1253
39. Traini D., Young P.M., Thielmann F., and Acharya M. the influence of lactose pseudopolymorphic form on salbutamol sulfate-lactose interactions in DPI formulations. Drug Dev. Ind. Pharm. 34 (2008) 992-1001
40. Young P.M., Sung A., Traini D., Kwok P., Chiou H., and Chan H.-K. Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhalers carrier-based systems. Pharm. Res. 24 (2007) 963-970